TriSalus Life Sciences Highlights Clinical Data From Phase 1B Perio-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma at 2024 Asco Annual Meeting
TriSalus生命科學公司在2024年ASCO年會上突出了Perio-02臨床試驗的臨床數據，研究了通過壓力啓用藥物傳遞在肝細胞癌或肝內膽管癌患者中遞送Nelitolimod。